Federated Hermes, Inc. Roivant Sciences Ltd. Transaction History
Federated Hermes, Inc.
- $50.2 Billion
- Q2 2025
A detailed history of Federated Hermes, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Federated Hermes, Inc. holds 27,749 shares of ROIV stock, worth $444,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,749
Previous 27,909
0.57%
Holding current value
$444,816
Previous $281,000
11.03%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
362Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$961 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$716 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$630 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$567 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$549 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...